GreeneeRT, MurrayT, BoldenS, WingoPA. Cancer statistics, 2000. CA Cancer J Clin2000;50:7–33.
2.
HyerJD, SilvestriG.Diagnosis and staging of lung cancer. Clin Chest Med2000;21:95–106.
3.
ReifM, SocinskiMA, RiveraMP. Evidence-based medicine in the treatment of non-small-cell lung cancer. Clin Chest Mine2000;21:107–120.
4.
ChuteCG, GreenbergER, BaronJ, KorsonR, BakerJ, YatesJ.Presenting conditions of 1539 population-based lung cancer patients by cell type and stage in New Hampshire and Vermont. Cancer1985;56:2107–2111.
5.
HydeL, HydeCl. Clinical manifestations of lung cancer. Chest1974;65:299–306.
DumonJF. A dedicated tracheobronchial stent. Chest1990;97:328–332.
8.
ColtHG, DumonJR.Airway stents: recent and future. Clin Chest Med1995;16:456–478.
9.
GeorgeP, IrvingJD, MantellB, RuddRM. Covered expandable metal stent for recurrent tracheal obstruction. Lancet1990;335:582–584.
10.
MonnierP, MudryA, StanzelF, HarussingerK, HeitzM, ProbstR, BollingerCT. The use of the covered Wallstent for the palliative treatment of inoperable tracheobronchial cancers: a prospective, multicenter study. Chest1996;110:1161–1168.
11.
BollingerCT, HeitzM, HauserR, ProbstR, PerruchoudAP. An airway Wallstent for the treatment of tracheobronchial malignancies. Thorax1996;51:1127–1129.
12.
FreitagL, EickerK, DonovanTJ, et al. Mechanical properties of airway stents. J Bronch1995;2:270–278.
BollingerCT, ProbstR, TschoppK, SolarM, PerruchoudAP. Silicone stents in the management of inoperable tracheobronchial stenosis: indications and limitations. Chest1993;104:1653–1659.
15.
HautmannJ, HuberRM, PfeiferK, et al. Flexible fiberoptic bronchoscopy: a safe and effective method for endobronchial metal stent implantation. Chest1996;110(Suppl):7S.
16.
WilsonGE, WalshawMJ, HindCRK. Treatment of large airway obstruction in lung cancer using expandable metal stents inserted under direct vision via the fiberoptic bronchoscope. Thorax1996;51:248–252.
17.
KovitzKL, ConfortiJ, BaboG, et al. Quantification of quality of life (QOL) after relief of airway obstruction (abstract). Am J Respir Crit Care Med1998;157(Suppl):A705.
18.
MontazeriA, GillisCR, McEwenJ.Quality of life in patients with lung cancer: a review of literature from 1970 to 1995. Chest1998;113:467–481.
19.
VergnonJM, CostesF, BayonMC, EmonotA.Efficacy of tracheal and bronchial stent placement on respiratory function tests. Chest1995;107:741–746.
20.
GelbAF, ZamelN, ColchenA, TashkinDP, MaurerJR, PattersonGA, EpsteinJD. Physiologic studies of tracheobronchial stents in airway obstruction. Am Rev Respir Dis1992;146:1088–1090.
21.
DalbarGR, BeamisJF, ZhangX.Tracheobronchial stents: a seven year experience (abstract). Am J Respir Crit Care Med1996;153(Suppl):A448.
22.
HauckRW, RomerW, SchulzC, LembeckRM, SchomigA, SchweigerM.Ventilation perfusion scintigraphy and lung function testing to assess metal stent efficacy. J Nucl Med1997;38:1584–1589.
23.
Medical Research Council Lung Cancer Working Party. A Medical Research Council (MRC) randomized trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Br J Cancer1992;65:934–941.
24.
SullivanFJ. Palliative radiotherapy for lung cancer. In: Lung cancer principles and practice. PassHI, MitchellJB, JohnsonDH, TurrisiAT, editors. Philadelphia: Lippincott-Raven; 1996:775–789.
25.
SteinhauserKE, ClippEC, McNeillyM, ChristakisNA, McIntyreLM, TulskyJA. In search of a good death: observations of patients, families, and providers. Ann Intern Med2000;132:825–832.
26.
CleelandCS, GoninR, HatfieldAK, EdmonsonJH, BlumRH, StewartJA, PandyaKJ. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med1994;330:592–596.
27.
WHO Expert Committee. Cancer pain relief and palliative care. Report of a WHO Expert Committee. Geneva, Switzerland: World Health Organization; 1990.
28.
ZechDE, GrondS, LynchJ, HertelD, LehmannKA. Validation of World Health Organization guidelines for cancer pain relief: a 10-year prospective study. Pain1995;63:65–76.
29.
GrondS, ZechD, SchngSA, LynchJ, LehmannKA. Validation of World Health Organization guidelines for cancer pain relief during the last days and hours of life. J Pain Symptom Manage1991;6:411–422.
30.
Easing cancer pain: improving relief, reducing distress. CA Cancer J Clin2000;50(2 Mar/Apr):70–116.
31.
US Dept of Health and Human Services. Clinical Practice Guideline: Management of cancer pain; 1994(9).
32.
MarshallKA. Managing cancer pain: basic principles and invasive treatments. Mayo Clin Proc1996;71:472–477.
33.
BloomfieldDJ. Should bisphosphonates be part of the standard therapy of patients with multiple myeloma or bone metastases from other cancers? An evidence-based review. J Clin Oncol1998;16:1218–1225.
34.
GrauerA, ZieglerR.[Bisphosphonate therapy in the management of skeletal metastases.]Orthopade1998;27(4):231–239. (article in German)
35.
ColemanRE, PurohitOP, VinholesJJ, ZekriJ.High dose pamidronate: clinical and biochemical effects in metastatic bone disease. Cancer1997;80:1686–1690.
36.
National Hospice Organization. Standards of a hospice program of care. Hosp J1994;9:39–74.
37.
Cancer pain relief and palliative care. Technical Report Series 804. Geneva: World Health Organization; 1990: 11.
38.
ChristakisAN, EscarceJJ. Survival of Medicare patients after enrollment in hospice programs. N Engl J Med1996;335:172–178.
39.
WeeksJC, CookEF, O'DaySJ, PetersonLM, WengerN, RedingD, et al. Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA1998;279:1709–1714.
40.
SilvestriGA, ZollerJ, PritchardR, Rocha LimaC, NeitertP, ShealyK.Patterns of practice in the treatment of metastatic lung cancer (abstract). Am J Respir Crit Care Med2000;161Suppl:A766.
41.
SilvestriGA, PritchardRS, WelchHG. Preference for chemotherapy among patients with advanced non-small cell lung cancer: a descriptive study based on scripted interviews. BMJ1998;317:771–775.
